Kasr alainy school of medicine
Cairo, 11562, Egypt
NCT Number: NCT05605431
Chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea(OSA) are common disorders ,the co-existence of both conditions is called overlap syndrome Smoking , obesity , airway resistance and inflammation are considered risk factors for both conditions ,interestingly either COPD and OSA are associated with increased cardiovascular complications with further increased risk in overlap syndrome Multiple theories could explain that one disorder can predispose or exaggerate the other. For example, in COPD cigarette smoking and inhaled steroids are linked to myopathy of upper airway dilator muscles. Moreover in core-pulmonale redistribution of edema fluid in supine position during sleep can also contribute to or exacerbate OSA .
On the other hand , OSA patients might smoke frequently and more heavily to compensate for excessive daytime sleepiness and to help them to lose weight , which results in exaggerated airway inflammation and exacerbate COPD. Rationale of the study was to assess the prevalence and predictors of OSA among patients with stable COPD.
Looking for future studies?
Notify Me25 year–76 year
All sexes
Observational
Cairo, 11562, Egypt
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
over nightSleep study
Time frame: 6 months
to assess the percentage of OSA among COPD patients
Cairo University
Other
Predictors of Obstructive Sleep Apnea in Patients With Chronic Obstructive Pulmonary Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05395390
COPD, COVID-19
College Station, Texas, United States
View Trial DetailsNCT05857475
COPD, Chronic Disease
Ratchathewi, Bangkok, Thailand
View Trial DetailsNCT02856633
Acute Otitis Media, Arrhythmias, Cardiac
Oakville, Ontario, Canada
View Trial DetailsNCT01801761
COPD, Chronic Disease
Taipei, Taiwan
View Trial Details